InterventionsHuman trial
Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, in Participants with and without Diabetes Mellitus in a Pooled Analysis of Two Phase 3 Trials
ADA Scientific Sessions 2026 Abstract
The paper
LEPOR N, PARHAM J, CATAPANO AL et al.
ADA Scientific Sessions 2026 Abstract · 7 Jun 2026
Presented at ADA Scientific Sessions 2026 · Oral 1246-OR